{"transactions":[{"id":1084734,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-18T16:05:40.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":19434,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Simran Investment Group"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein."},{"field":"shares","element":"transactionShares","label":"F3","text":"The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis.  The RSUs will vest in full on June 18, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents RSUs issued to the Reporting Person in lieu of director retainer fees of $55,000. The RSUs will vest in full on June 18, 2026."}],"balance_after":415346,"source":{"system":"sec-edgar","filing":"0001140361-25-026408","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036125026408/form4.xml","form_type":"4"}},{"id":1084733,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-18T16:05:40.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Simran Investment Group"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis.  The RSUs will vest in full on June 18, 2026."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis.  The RSUs will vest in full on June 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis.  The RSUs will vest in full on June 18, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents RSUs issued to the Reporting Person in lieu of director retainer fees of $55,000. The RSUs will vest in full on June 18, 2026."}],"balance_after":395912,"source":{"system":"sec-edgar","filing":"0001140361-25-026408","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036125026408/form4.xml","form_type":"4"}},{"id":1380064,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-29T16:58:22.000Z","date":"2024-09-26","kind":"grant","planned":false,"acquired":true,"shares":303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 303 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on September 26, 2025."}],"balance_after":303,"derivative":{"exercise_price":17.6,"expiration_date":"2034-09-26","underlying":"Common Stock","underlying_shares":303},"source":{"system":"sec-edgar","filing":"0001140361-24-044546","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036124044546/form4.xml","form_type":"4"}},{"id":1380063,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-29T16:58:22.000Z","date":"2024-09-26","kind":"grant","planned":false,"acquired":true,"shares":204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 204 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on September 26, 2025."}],"balance_after":204,"derivative":{"exercise_price":17.6,"expiration_date":"2034-09-26","underlying":"Common Stock","underlying_shares":204},"source":{"system":"sec-edgar","filing":"0001140361-24-044546","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036124044546/form4.xml","form_type":"4"}},{"id":1473230,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T16:10:24.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":2660,"price":15.04,"value":40006.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 2,660 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025. This option was issued to the Reporting Person in lieu of director retainer fees of $40,000."}],"balance_after":2660,"derivative":{"exercise_price":22.86,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":2660},"source":{"system":"sec-edgar","filing":"0001140361-24-030725","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036124030725/form4.xml","form_type":"4"}},{"id":1473229,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T16:10:24.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":23944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 23,944 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025."}],"balance_after":23944,"derivative":{"exercise_price":22.86,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":23944},"source":{"system":"sec-edgar","filing":"0001140361-24-030725","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036124030725/form4.xml","form_type":"4"}},{"id":1484990,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-10T10:34:56.000Z","date":"2024-03-21","kind":"sale","planned":false,"acquired":false,"shares":274000,"price":28.4341,"value":7790943.4,"ownership":{"direct":false,"nature":"By Simran Investment Group"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein."}],"balance_after":365912,"source":{"system":"sec-edgar","filing":"0001140361-24-029438","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036124029438/form4.xml","form_type":"4/A","original_submission_date":"2024-03-25"}},{"id":1561907,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-03-25T20:58:04.000Z","date":"2024-03-21","kind":"sale","planned":false,"acquired":false,"shares":274000,"price":28.4341,"value":7790943.4,"ownership":{"direct":false,"nature":"By Simran Investment Group"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein."}],"balance_after":365912,"source":{"system":"sec-edgar","filing":"0001140361-24-015103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036124015103/form4.xml","form_type":"4"}},{"id":1739131,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-11-16T19:24:13.000Z","date":"2023-11-15","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":22.5323,"value":450646.0,"ownership":{"direct":false,"nature":"By Simran Investment Group"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the \"Lock-Up Agreement\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold by the reporting person pursuant to an exemption to the Lock-Up Agreement in order to pay certain tax obligations. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein."}],"balance_after":1296497,"source":{"system":"sec-edgar","filing":"0001140361-23-053713","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036123053713/form4.xml","form_type":"4"}},{"id":1770500,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-10-02T21:02:27.000Z","date":"2023-09-29","kind":"sale","planned":false,"acquired":false,"shares":4677,"price":21.1383,"value":98863.8291,"ownership":{"direct":false,"nature":"By Simran Investment Group"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the \"Lock-Up Agreement\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold by the reporting person pursuant to an exemption to the Lock-Up Agreement in order to pay certain tax obligations. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein."}],"balance_after":1316497,"source":{"system":"sec-edgar","filing":"0001140361-23-046452","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036123046452/form4.xml","form_type":"4"}},{"id":1770499,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-10-02T21:02:27.000Z","date":"2023-09-28","kind":"sale","planned":false,"acquired":false,"shares":10312,"price":21.0318,"value":216879.9216,"ownership":{"direct":false,"nature":"By Simran Investment Group"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the \"Lock-Up Agreement\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold by the reporting person pursuant to an exemption to the Lock-Up Agreement in order to pay certain tax obligations. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein."}],"balance_after":1321174,"source":{"system":"sec-edgar","filing":"0001140361-23-046452","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036123046452/form4.xml","form_type":"4"}},{"id":1844250,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-26T19:47:57.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":2872,"price":13.93,"value":40006.96,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 2,872 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024. This option was issued to the Reporting Person in lieu of director retainer fees of $40,000."}],"balance_after":2872,"derivative":{"exercise_price":21.56,"expiration_date":"2033-06-22","underlying":"Common Stock","underlying_shares":2872},"source":{"system":"sec-edgar","filing":"0001140361-23-031529","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036123031529/form4.xml","form_type":"4"}},{"id":1844249,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-26T19:47:57.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":25850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024."}],"balance_after":25850,"derivative":{"exercise_price":21.56,"expiration_date":"2033-06-22","underlying":"Common Stock","underlying_shares":25850},"source":{"system":"sec-edgar","filing":"0001140361-23-031529","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036123031529/form4.xml","form_type":"4"}},{"id":2231510,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T21:07:39.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":5876,"price":6.8,"value":39956.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 5,876 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023. This option was issued to the Reporting Person in lieu of director retainer fees of $40,000."}],"balance_after":5876,"derivative":{"exercise_price":10.77,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":5876},"source":{"system":"sec-edgar","filing":"0001140361-22-023151","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036122023151/form4.xml","form_type":"4"}},{"id":2231509,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T21:07:39.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":47745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 47,745 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023."}],"balance_after":47745,"derivative":{"exercise_price":10.77,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":47745},"source":{"system":"sec-edgar","filing":"0001140361-22-023151","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036122023151/form4.xml","form_type":"4"}},{"id":2342010,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-03-09T16:53:10.000Z","date":"2021-07-27","kind":"gift","acquired":false,"shares":621500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Simran Investment Group"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were gifted by the reporting person to a nonrevocable trust for the benefit of the reporting person's children. The reporting person has no voting or investment power over all securities owned by the trust."}],"balance_after":674901,"source":{"system":"sec-edgar","filing":"0001140361-22-008638","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036122008638/form4.xml","form_type":"4"}},{"id":2661265,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-06-21T16:52:12.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":400,"price":47.125,"value":18850.0,"ownership":{"direct":false,"nature":"By Simran Investment Group"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein were sold to cover certain tax liabilities.  The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein."}],"balance_after":1296401,"source":{"system":"sec-edgar","filing":"0001140361-21-021733","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036121021733/form4.xml","form_type":"4"}},{"id":2661264,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-06-21T16:52:12.000Z","date":"2021-06-16","kind":"sale","acquired":false,"shares":34685,"price":46.8457,"value":1624843.1045,"ownership":{"direct":false,"nature":"By Simran Investment Group"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein were sold to cover certain tax liabilities.  The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein."}],"balance_after":1296801,"source":{"system":"sec-edgar","filing":"0001140361-21-021733","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036121021733/form4.xml","form_type":"4"}},{"id":2666415,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T20:13:40.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":1529,"price":29.42,"value":44983.18,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 1,529 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022. This option was issued to the Reporting Person in lieu of director retainer fees of $45,000."}],"balance_after":1529,"derivative":{"exercise_price":47.25,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":1529},"source":{"system":"sec-edgar","filing":"0001140361-21-021302","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036121021302/form4.xml","form_type":"4"}},{"id":2666414,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T20:13:40.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":12236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 12,236 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022."}],"balance_after":12236,"derivative":{"exercise_price":47.25,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":12236},"source":{"system":"sec-edgar","filing":"0001140361-21-021302","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036121021302/form4.xml","form_type":"4"}},{"id":3105645,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-18T21:38:51.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":3206,"price":12.16,"value":38984.96,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents a right to purchase a total of 3,206 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 16, 2021. This option was issued to the Reporting Person in lieu of director retainer fees of $39,000."}],"balance_after":3206,"derivative":{"exercise_price":19.9,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":3206},"source":{"system":"sec-edgar","filing":"0001140361-20-014239","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036120014239/form4.xml","form_type":"4"}},{"id":3105644,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-18T21:38:51.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":9784,"price":12.16,"value":118973.44,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 9,784 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 16, 2021."}],"balance_after":9784,"derivative":{"exercise_price":19.9,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":9784},"source":{"system":"sec-edgar","filing":"0001140361-20-014239","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036120014239/form4.xml","form_type":"4"}},{"id":3105643,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-18T21:38:51.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 20,000 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 16, 2021."}],"balance_after":20000,"derivative":{"exercise_price":19.9,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-20-014239","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036120014239/form4.xml","form_type":"4"}},{"id":3682691,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-30T18:35:49.000Z","date":"2019-01-28","kind":"grant","acquired":true,"shares":4666,"price":9.96,"value":46473.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option represents a right to purchase a total of 4,666 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on January 28, 2020. This option was issued to the Reporting Person in lieu of director retainer fees of $46,500."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 4,666 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on January 28, 2020. This option was issued to the Reporting Person in lieu of director retainer fees of $46,500."}],"balance_after":4666,"derivative":{"exercise_price":14.56,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":4666},"source":{"system":"sec-edgar","filing":"0001140361-19-002009","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036119002009/form4.xml","form_type":"4"}},{"id":3682690,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-30T18:35:49.000Z","date":"2019-01-28","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 30,000 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on January 28, 2020."}],"balance_after":30000,"derivative":{"exercise_price":14.56,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001140361-19-002009","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000114036119002009/form4.xml","form_type":"4"}},{"id":3976624,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-02T20:12:13.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":3300,"price":14.09,"value":46497.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option represents a right to purchase a total of 3,300 shares of the Issuer's Common Stock, 1,116 of which will become fully vested and exercisable on March 29, 2019, with the remaining 2,184 shares vesting in equal monthly installments over the following two years. This option was issued to the Reporting Person in lieu of director retainer fees of $46,500."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 3,300 shares of the Issuer's Common Stock, 1,116 of which will become fully vested and exercisable on March 29, 2019, with the remaining 2,184 shares vesting in equal monthly installments over the following two years. This option was issued to the Reporting Person in lieu of director retainer fees of $46,500."}],"balance_after":3300,"derivative":{"exercise_price":18.75,"expiration_date":"2028-03-29","underlying":"Common Stock","underlying_shares":3300},"source":{"system":"sec-edgar","filing":"0000899243-18-009117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000089924318009117/doc4.xml","form_type":"4"}},{"id":3976623,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":77370,"kind":"person","name":"Makker Gotham","position":1,"cik":"0001726391","reported_name":"Makker Gotham","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-02T20:12:13.000Z","date":"2018-03-29","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, 13,336 of which will become fully vested and exercisable on March 29, 2019, with the remaining 26,664 shares vesting in equal monthly installments over the following two years."}],"balance_after":40000,"derivative":{"exercise_price":18.75,"expiration_date":"2028-03-29","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-18-009117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726391/000089924318009117/doc4.xml","form_type":"4"}}]}